跳至主要内容
临床试验/NCT07270211
NCT07270211尚未招募不适用

Magnetocardiography in Long QT Syndrome: A Prospective Study of Its Clinical and Prognostic Utility

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
Mayo Clinic
入组人数
100
试验地点
2
主要终点
Number of successful dofetilide loading using Magnetocardiography

研究概览

简要总结

The primary objective of this observational study is to evaluate whether magnetocardiography (MCG) findings more accurately predict clinical outcomes in patients with acquired Long QT syndrome compared to ECG. The secondary objective is to assess differences in QT interval length between MCG and ECG. The primary safety objective is to characterize the safety profile of the CardiAQ MCG device.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years on the date of consent
  • Ability for participant to comply with study requirements
  • Written informed consent
  • Confirmed diagnosis of atrial fibrillation and receiving dofetilide for rhythm control in the inpatient setting.

排除标准

  • Pregnant or breastfeeding
  • Active thoracic metal implants (including pacemaker, insertable cardiac monitor, or internal defibrillators).
  • External electrical pads or devices (e.g. Pacer pads, ECG electrodes, heart rate patch), that must remain on patient's chest during MCG scan
  • Inability to lie down in a supine/inclined position and stay still on the examination bed
  • Clinical conditions that in the opinion of the Investigator would compromise the safety of the patient or ability to complete the protocol

研究组 & 干预措施

Subjects diagnosed with atrial fibrillation

干预措施: Magnetocardiography (Diagnostic Test)

结局指标

主要结局

Number of successful dofetilide loading using Magnetocardiography

时间窗: Baseline

Dofetilide loading is considered successful if the following conditions are met: 1. No excessive QTc prolongation QTc remains \<500 ms, and no \>15% increase from baseline. 2. No sustained VT or recurrent/symptomatic non-sustained VT (NSVT) suggestive of proarrhythmia. 3. No symptomatic bradycardia or hemodynamic instability 4. Stable renal function 5. No deterioration necessitating dose reduction or discontinuation. 6. Discharge on a stable dose

Number of successful dofetilide loading using Electrocardiogram

时间窗: Baseline

Dofetilide loading is considered successful if the following conditions are met: 1. No excessive QTc prolongation QTc remains \<500 ms, and no \>15% increase from baseline. 2. No sustained VT or recurrent/symptomatic non-sustained VT (NSVT) suggestive of proarrhythmia. 3. No symptomatic bradycardia or hemodynamic instability 4. Stable renal function 5. No deterioration necessitating dose reduction or discontinuation. 6. Discharge on a stable dose

次要结局

  • Magnetocardiography - QT interval length(Baseline)
  • Electrocardiogram - QT interval length(Baseline)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamad Adnan Alkhouli

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验

MCG In Long QT Syndrome | 临床试验